These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4562545)

  • 1. [Natural acridine derivatives].
    Johne S; Gröger D
    Pharmazie; 1972 Apr; 27(4):195-208. PubMed ID: 4562545
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships for thiolytic cleavage rates of antitumor drugs in the 4'-(9-acridinylamino)methanesulfonanilide series.
    Cain BR; Wilson WR; Baguley BC
    Mol Pharmacol; 1976 Nov; 12(6):1027-35. PubMed ID: 1004488
    [No Abstract]   [Full Text] [Related]  

  • 3. Acridine: a versatile heterocyclic nucleus.
    Kumar R; Kaur M; Kumari M
    Acta Pol Pharm; 2012; 69(1):3-9. PubMed ID: 22574501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acridine and its derivatives: a patent review (2009 - 2013).
    Zhang B; Li X; Li B; Gao C; Jiang Y
    Expert Opin Ther Pat; 2014 Jun; 24(6):647-64. PubMed ID: 24848259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships for acridine-substituted analogues of the mixed topoisomerase I/II inhibitor N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Spicer JA; Gamage SA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(12):1919-29. PubMed ID: 9191970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A search for new antitumor compounds. Biological studies. 3. Antitumor properties of 14 new acridine derivatives.
    Radzikowski C; Ledóchowski Z; Ledóchowski A; Peryt J; Hrabowska M; Konopa J; Balk M; Jereczek E
    Arch Immunol Ther Exp (Warsz); 1967; 15(2):233-40. PubMed ID: 6050441
    [No Abstract]   [Full Text] [Related]  

  • 7. A search for new antitumor compounds. Biological studies. IV. Antitumor properties of 21 new acridine derivatives.
    Radzikowski C; Ledóchowski Z; Ledóchowski A; Bogucka M; Hrabowska M; Konopa J; Balk M; Jereczek E
    Arch Immunol Ther Exp (Warsz); 1967; 15(2):241-8. PubMed ID: 6050442
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites?
    Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644
    [No Abstract]   [Full Text] [Related]  

  • 9. Niche for acridine derivatives in anticancer therapy.
    Galdino-Pitta MR; Pitta MG; Lima MC; Galdino LS; Pitta RI
    Mini Rev Med Chem; 2013 Jul; 13(9):1256-71. PubMed ID: 22697517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interest of acridine derivatives in the anticancer chemotherapy.
    Demeunynck M; Charmantray F; Martelli A
    Curr Pharm Des; 2001 Nov; 7(17):1703-24. PubMed ID: 11562307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer agents. II. Synthesis and antimycobacterial activity of some novel methylglyoxal derivatives.
    Barry VC; Byrne J; Conalty ML; O'Sullivan JF
    Proc R Ir Acad B; 1967 Jan; 65(9):269-84 contd. PubMed ID: 4963035
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of pharmacological activity several acridine derivatives with cytostatic and oncostatic properties.
    Gieldanowski J
    Mater Med Pol; 1976; 8(3):252-7. PubMed ID: 1034858
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterocyclic derivatives of 2-chloroethyl sulfide with antitumor activity.
    Peck RM; O'Connell AP; Creech HJ
    J Med Chem; 1966 Mar; 9(2):217-21. PubMed ID: 5911801
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on tumor chemotherapeutic agents: synthesis of 9-hydrazinoacridine derivatives].
    Xie KQ; Xu JG
    Yao Xue Xue Bao; 1984 Jun; 19(6):466-70. PubMed ID: 6536158
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biosynthesis of the acridine alkaloid arborinine].
    Johne S; Bernasch H; Gröger D
    Pharmazie; 1970 Dec; 25(12):777-9. PubMed ID: 5499284
    [No Abstract]   [Full Text] [Related]  

  • 16. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linking.
    Pawlak K; Pawlak JW; Konopa J
    Cancer Res; 1984 Oct; 44(10):4289-96. PubMed ID: 6467190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diacridines, bifunctional intercalators. Chemistry and antitumor activity.
    Chen TK; Fico R; Canellakis ES
    J Med Chem; 1978 Sep; 21(9):868-74. PubMed ID: 722754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of structure of purine and pyrimidine nucleosides to antitumor activity.
    Goldin A; Wood HB; Engle RR
    Cancer Chemother Rep 2; 1968 Oct; 1(1):1-272. PubMed ID: 5743752
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.